XBI & Biotech Sector Analysis (video)
Analysis of XBI (Biotech Sector ETF) and several of the largest biotech stocks including AMGN, ABBV, CELG & GILD.
AMGN & XBI Biotech Sector Breakdown
I haven't posted much analysis on the biotech sector lately as my opinion wasn't very strong. However, this bearish candle is XBI today is both a breakdown below the bearish rising wedge pattern (white lines) as well as a failure from the recent bullish pennant (blue lines) breakout. My expectation is for a continued move [...]
Earnings Reports To Watch for After The Close
Here are a few companies reporting earnings after the bell today that either have the potential to move the broad market tomorrow and/or might present a potential trading opportunity: AMD (Advance Micro Devices): One of the recent high-flying semiconductor & GPU manufacturers, currently poised to break above or below a triangle/consolidation pattern on the daily [...]
Analysis of QQQ & Top Components (video)
Analysis & the outlook for QQQ as well as the largest components of the Nasdaq 100, which account for the bulk of the performance of that leading index.
QQQ Top 10 Components Analysis (video)
This video begins with a brief overview of QQQ (Nasdaq 100 tracking ETF) followed by the near & long-term outlook, including some key supports, chart patterns & price targets, for the 10 largest components* of QQQ which alone account for over 50% of the returns of that market leading index. * I had mistakenly left [...]
Nasdaq 100 & Top 10 Components Analysis (video)
A look at the short & long-term charts of the Nasdaq 100, QQQ & the top 10 components which are responsible for over 50% of the performance of that leading stock index. The following index/sector/stocks are covering in this order: $NDX/QQQ,AAPL,GOOG/GOOGL, MSFT, AMZN, FB, INTC, CMCSA, AMGN & XBI (Biotech Sector ETF).
Biotech Sector Outlook (video)
As this video ran longer than I had anticipated, I'll sum up my thoughts for those that don't have the time or inclination to watch the entire video. Despite the fact that the biotech sector has been drifting higher in a choppy but overall bullish trading range since the February lows, there is very little, [...]